NCT00664729

Brief Summary

Reductions in fat oxidation and resting metabolic rate (RMR) are associated with normal aging and are accelerated with menopause. As a result, postmenopausal women have an increased risk of abdominal obesity and ultimately the metabolic complications that lead to the insulin resistance syndrome and its associated risks (hyperlipidemia, type 2 diabetes, and coronary heart disease). Thus, there is a need to determine the most successful treatment to reduce visceral obesity in postmenopausal women. The purpose of this study is to determine if dietary-induced weight loss alone and/or weight loss combined with exercise at low and high- intensities differentially affect the reduction in visceral adipose tissue in postmenopausal women with abdominal obesity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2002

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2002

Completed
5.5 years until next milestone

First Submitted

Initial submission to the registry

April 21, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 23, 2008

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2008

Completed
Last Updated

August 1, 2018

Status Verified

July 1, 2018

Enrollment Period

6 years

First QC Date

April 21, 2008

Last Update Submit

July 30, 2018

Conditions

Keywords

Abdominalobesityexerciseintensityweight losswomen

Outcome Measures

Primary Outcomes (1)

  • Abdominal visceral fat volume

    Baseline, follow-up

Secondary Outcomes (1)

  • HDL cholesterol Triglyceride concentrations Glucose tolerance

    Baseline and Follow-up

Study Arms (3)

1

ACTIVE COMPARATOR

Caloric Restriction

Behavioral: Caloric Restriction

2

EXPERIMENTAL

Caloric restriction + Moderate-intensity aerobic exercise

Behavioral: Caloric Restriction + Low-Intensity aerobic exercise

3

EXPERIMENTAL

Caloric restriction + Vigorous-intensity aerobic exercise

Behavioral: Caloric Restriction plus High-intensity aerobic exercise

Interventions

Reduced calorie diet (400 kcal/day deficit)

Also known as: Diet Only
1

400 kcal/day deficit plus 3 days/week aerobic exercise at 45-50% maximal aerobic fitness

Also known as: Diet+Low-Intensity AEX
2

400 kcal/day deficit and 3 d/week of aerobic exercise at 65-75% maximal fitness

Also known as: Diet+High-intensity AEX
3

Eligibility Criteria

Age50 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Currently 50 - 70 years of age (at screening)
  • Post-menopausal at least 1 year
  • Waist diameter of at least 34"
  • Able to attend exercise classes 3 times per week
  • BMI between 25 \& 40 kg/m2
  • MMSE \> 25

You may not qualify if:

  • Exercises regularly (ie- more than twice a week for more than 15 minutes per session)?
  • Uncontrolled diabetes mellitus or insulin-controlled diabetes?
  • Does not drive and does not have a reliable way to pick up meals once a week
  • Cancer in past 5 years except skin cancer
  • Unwilling or unable to eat prepared foods (non-compliant during test week)
  • Unwilling or unable to record food intake accurately
  • Self-reported weight loss or gain \>5% in past 6 months
  • Smoking within past year, or use of tobacco or nicotine product
  • Coronary artery disease, liver disease, renal disease, or other systemic disorders
  • Pulmonary disease
  • Current use of thiazide diuretics, beta blockers or steroids
  • Current use of more than one anti-hypertensive medication
  • Current use of anti-depressants or hormone replacement therapy
  • Gross physical impairment
  • Blindness or retinopathy
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest University Health Sciences

Winston-Salem, North Carolina, 27157, United States

Location

Related Publications (5)

  • You T, Murphy KM, Lyles MF, Demons JL, Lenchik L, Nicklas BJ. Addition of aerobic exercise to dietary weight loss preferentially reduces abdominal adipocyte size. Int J Obes (Lond). 2006 Aug;30(8):1211-6. doi: 10.1038/sj.ijo.0803245. Epub 2006 Jan 31.

  • You T, Yang R, Lyles MF, Gong D, Nicklas BJ. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors. Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E741-7. doi: 10.1152/ajpendo.00419.2004. Epub 2004 Nov 23.

  • Wang X, You T, Murphy K, Lyles MF, Nicklas BJ. Addition of Exercise Increases Plasma Adiponectin and Release from Adipose Tissue. Med Sci Sports Exerc. 2015 Nov;47(11):2450-5. doi: 10.1249/MSS.0000000000000670.

  • You T, Disanzo BL, Wang X, Yang R, Gong D. Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise. Lipids Health Dis. 2011 Oct 28;10:194. doi: 10.1186/1476-511X-10-194.

  • Nicklas BJ, Wang X, You T, Lyles MF, Demons J, Easter L, Berry MJ, Lenchik L, Carr JJ. Effect of exercise intensity on abdominal fat loss during calorie restriction in overweight and obese postmenopausal women: a randomized, controlled trial. Am J Clin Nutr. 2009 Apr;89(4):1043-52. doi: 10.3945/ajcn.2008.26938. Epub 2009 Feb 11.

MeSH Terms

Conditions

Obesity, AbdominalMetabolic SyndromeObesityMotor ActivityWeight Loss

Interventions

Caloric Restriction

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesBehaviorBody Weight Changes

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsEnergy IntakeDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Barbara J Nicklas, PhD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2008

First Posted

April 23, 2008

Study Start

November 1, 2002

Primary Completion

November 1, 2008

Study Completion

November 1, 2008

Last Updated

August 1, 2018

Record last verified: 2018-07

Locations